Aktiesnakken — Juni 2013
-
Det er unfair overfor de andre virksomheder. Skal vi egenhændigt kurerer alle kendte sygdomme?
-
Er der ikke en mab undervejs.
-
Teprototurbomab
-
Vi må efterhånden dele firmaet op.
-
De udvikler det mod de tonde øje?
-
Hvad skal de nu ind i øjet efter?
-
Det spiller jo ikke den store rolle i casen.rg1507 er vel sat til 0 hos novod også?
-
Må lige tjekke, men vender mig lige om i sengen. Stod kun op fordi I støjede så meget
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind